ContextVision AB (publ) (OSL:CONTX)
4.420
-0.080 (-1.78%)
Nov 4, 2026, 4:25 PM CET
ContextVision AB Market Cap
ContextVision AB has a market cap or net worth of 329.33 million as of November 4, 2026. It is the 32,363rd most valuable company in the world and the 223rd biggest in Norway. Its market cap has increased by 0.65% in one year.
Market Cap
329.33M
Enterprise Value
260.25M
Revenue
121.88M
Global Rank
Country Rank
#223 Norway
PE Ratio
24.71
ChartMarket Cap Chart
Since March 18, 1997, ContextVision AB's market cap has increased from 296.00M to 329.33M, an increase of 11.26%. That is a compound annual growth rate of 0.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 329.33M | 3.14% |
| Dec 30, 2025 | 319.30M | -24.96% |
| Dec 30, 2024 | 425.52M | -28.57% |
| Dec 29, 2023 | 595.73M | -15.75% |
| Dec 30, 2022 | 707.14M | -44.49% |
| Dec 30, 2021 | 1.27B | -25.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 5.51B |
| Circio Holding ASA | 2.91B |
| Nordhealth AS | 1.93B |
| Thor Medical ASA | 1.74B |
| Lytix Biopharma ASA | 615.20M |
| Gentian Diagnostics ASA | 610.62M |
| INIFY Laboratories AB | 591.11M |
| Zelluna ASA | 567.35M |